[go: up one dir, main page]

TW259709B - - Google Patents

Info

Publication number
TW259709B
TW259709B TW081102960A TW81102960A TW259709B TW 259709 B TW259709 B TW 259709B TW 081102960 A TW081102960 A TW 081102960A TW 81102960 A TW81102960 A TW 81102960A TW 259709 B TW259709 B TW 259709B
Authority
TW
Taiwan
Prior art keywords
linear
glutathione
branched
disorder
induced tissue
Prior art date
Application number
TW081102960A
Other languages
English (en)
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of TW259709B publication Critical patent/TW259709B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW081102960A 1991-04-15 1992-04-15 TW259709B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10816391 1991-04-15

Publications (1)

Publication Number Publication Date
TW259709B true TW259709B (zh) 1995-10-11

Family

ID=14477570

Family Applications (2)

Application Number Title Priority Date Filing Date
TW081102960A TW259709B (zh) 1991-04-15 1992-04-15
TW084105578A TW423970B (en) 1991-04-15 1992-04-15 Preventive or therapeutic agent for lung injury caused by active oxygens and free radicals

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW084105578A TW423970B (en) 1991-04-15 1992-04-15 Preventive or therapeutic agent for lung injury caused by active oxygens and free radicals

Country Status (10)

Country Link
EP (1) EP0538476B1 (zh)
JP (1) JP2873089B2 (zh)
KR (1) KR0159949B1 (zh)
AT (1) ATE143593T1 (zh)
AU (1) AU655814B2 (zh)
CA (1) CA2083609C (zh)
DE (1) DE69214250T2 (zh)
SG (1) SG82552A1 (zh)
TW (2) TW259709B (zh)
WO (1) WO1992018120A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
WO2007005990A2 (en) * 2005-07-01 2007-01-11 Rosalind Franklin University Of Medicine And Science Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke
TW201201712A (en) 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3784905T2 (de) * 1986-07-07 1993-08-05 Teijin Ltd Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten.
JP2569060B2 (ja) * 1987-07-14 1997-01-08 帝人株式会社 グルタミルシスティン誘導体、その製造法およびそれを有効成分とする組織グルタチオンレベル向上剤
JP2553090B2 (ja) * 1987-07-21 1996-11-13 帝人株式会社 組織グルタチオンレベル向上剤
US4968671A (en) * 1987-11-26 1990-11-06 Yamanouchi Pharmaceutical Co., Ltd. Therapeutic agents for ischemic heart diseases

Also Published As

Publication number Publication date
EP0538476A4 (en) 1993-08-04
CA2083609C (en) 1997-03-18
KR0159949B1 (ko) 1998-12-01
SG82552A1 (en) 2001-08-21
DE69214250T2 (de) 1997-04-30
EP0538476A1 (en) 1993-04-28
TW423970B (en) 2001-03-01
DE69214250D1 (de) 1996-11-07
ATE143593T1 (de) 1996-10-15
EP0538476B1 (en) 1996-10-02
AU1555092A (en) 1992-11-17
WO1992018120A1 (en) 1992-10-29
JP2873089B2 (ja) 1999-03-24
AU655814B2 (en) 1995-01-12
CA2083609A1 (en) 1992-10-16

Similar Documents

Publication Publication Date Title
DE69129193D1 (en) Triterpenderivat
ES2073889T3 (es) Composicion despigmentante que contiene unos derivados de arbutosido.
PH24503A (en) New pharmaceutical compositions having psychotropic activity
JPS6483011A (en) Melanization inhibitory drug for external use
DE60001544D1 (de) Kreatin, Karnitin und/oder Brenztraubensäure enthaltende kosmetische Zusammensetzungen
IL85236A (en) Microbicidal and fungicidal compositions containing thiazole derivatives, certain such novel compounds and their preparation
EP0529487A3 (en) Pacap derivatives having c-amp producing activity
TW259709B (zh)
AU562423B2 (en) Benzoic acid derivatives
DK0407815T3 (da) Præparat indeholdende polyprenylforbindelser til bløde kapsler
BR8600142A (pt) Processo para a preparacao de azolil-aroximetil-dimetil-pentinois,composicao fungicida,processo para o combate de fungos e para a preparacao de composicoes
EP0404936A4 (en) Preparation of vitamin d 2? and vitamin d 3?, or active vitamin d 2? and active vitamin d 3?, or their derivatives